WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 4 fonti

The amazing rise and shocking fall of the company that created Ozempic

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

Raccontata da

cincodias.elpais.com

theguardian.com

telegraph.co.uk

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

telegraph.co.ukStai leggendo10 mesi fa

The amazing rise and shocking fall of the company that created Ozempic

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

Timeline cronologica

lunedì 4 agosto 2025·cincodias.elpais.com
Novo Nordisk, de reinar en solitario con sus fármacos contra la obesidad a dilapidar sin freno su valor en Bolsa
La acción se derrumba un 70% desde máximos de hace un año, evaporando 430.000 millones en capitalización. La falta de reflejos ante la dura competencia y la amenaza de aranceles…
mercoledì 6 agosto 2025·theguardian.com
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply
Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

10 mesi fa

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Leggi questa versione → originale

cincodias.elpais.com11 mesi fa

Novo Nordisk, de reinar en solitario con sus fármacos contra la obesidad a dilapidar sin freno su valor en…

La acción se derrumba un 70% desde máximos de hace un año, evaporando 430.000 millones en capitalización. La falta de reflejos ante la dura competencia y la amenaza de aranceles minan el valor

Leggi questa versione → originale

theguardian.com10 mesi fa

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

Leggi questa versione → originale

mercoledì 6 agosto 2025·

telegraph.co.uk

Ozempic maker goes to war with ‘fake’ copycat jabs as sales slow

Novo Nordisk files 14 lawsuits in US against companies selling duplicate drugs

mercoledì 6 agosto 2025·

telegraph.co.uk

The amazing rise and shocking fall of the company that created Ozempic

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

giovedì 7 agosto 2025·

nytimes.com

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.